Popular glucose-lowering drugs also show no risk of hypoglycemia or pancreatic injury, and modest benefit for weight compared to placeboOne member of a widely prescribed class of drugs used to...
from Obesity / Weight Loss / Fitness News From Medical News Today http://ift.tt/1cIu90Y
mardi 9 juin 2015
weight loss fitnessFirst CVD outcome trial of a GLP-1 agonist finds no cardiac risk or benefit
Inscription à :
Publier les commentaires (Atom)
0 commentaires:
Enregistrer un commentaire